Truscreen Group (ASX:TRU) Gross Margin %: 31.98% (As of Mar. 2025) — Near Median


What is Truscreen Group Gross Margin %?

Truscreen Group ASX:TRU Gross Margin % is 31.98% as of Mar. 2025, which is 4% above its 10-year median of 30.63. The stock has 6 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Truscreen Group ranks worse than 81.12% on this metric.

Gross Margin % is calculated as gross profit divided by its revenue. Truscreen Group's Gross Profit for the six months ended in Mar. 2025 was A$0.20 Mil. Truscreen Group's Revenue for the six months ended in Mar. 2025 was A$0.62 Mil. Therefore, Truscreen Group's Gross Margin % for the quarter that ended in Mar. 2025 was 31.98%.

Warning Sign:

Truscreen Group Ltd gross margin has been in long-term decline. The average rate of decline per year is -1.5%.


The historical rank and industry rank for Truscreen Group's Gross Margin % or its related term are showing as below:

ASX:TRU' s Gross Margin % Range Over the Past 10 Years
Min: -0.5   Med: 30.63   Max: 40.06
Current: 30.08


During the past 12 years, the highest Gross Margin % of Truscreen Group was 40.06%. The lowest was -0.50%. And the median was 30.63%.

ASX:TRU's Gross Margin % is ranked worse than
81.12% of 805 companies
in the Medical Devices & Instruments industry
Industry Median: 51.94 vs ASX:TRU: 30.08

Truscreen Group had a gross margin of 31.98% for the quarter that ended in Mar. 2025 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Truscreen Group was -1.50% per year.


Truscreen Group  (ASX:TRU) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Truscreen Group had a gross margin of 31.98% for the quarter that ended in Mar. 2025 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Truscreen Group Gross Margin % Related Terms


Truscreen Group Gross Margin % Historical Data

* Premium members only.

The historical data trend for Truscreen Group's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Truscreen Group Gross Margin % Chart

Truscreen Group Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.16 27.68 31.82 30.08 31.56

Truscreen Group Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Mar26
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.04 43.86 28.84 31.98 0.00

ASX:TRU vs ABT, SYK, MDT: Gross Margin % Comparison

For the Medical Devices subindustry, Truscreen Group's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Truscreen Group Gross Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Truscreen Group's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Truscreen Group's Gross Margin % falls into.



Truscreen Group Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Truscreen Group's Gross Margin for the fiscal year that ended in Mar. 2026 is calculated as

Gross Margin % (A: Mar. 2026 )=Gross Profit (A: Mar. 2026 ) / Revenue (A: Mar. 2026 )
=0.6 / 2.028
=(Revenue - Cost of Goods Sold) / Revenue
=(2.028 - 1.388) / 2.028
=31.56 %

Truscreen Group's Gross Margin for the quarter that ended in Mar. 2025 is calculated as


Gross Margin % (Q: Mar. 2025 )=Gross Profit (Q: Mar. 2025 ) / Revenue (Q: Mar. 2025 )
=0.2 / 0.616
=(Revenue - Cost of Goods Sold) / Revenue
=(0.616 - 0.419) / 0.616
=31.98 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Margin % →
What does a Gross Margin % of 31.98% mean?
Truscreen Group (ASX:TRU) has a Gross Margin % of 31.98% as of Mar. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Truscreen Group and its competitors. This is near median its historical median of 30.63. According to the industry distribution chart, Truscreen Group ranks #653 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 81.1%.
Is Truscreen Group's Gross Margin % too high?
Truscreen Group's current Gross Margin % of 31.98% is near median its 10-year median of 30.63. The Medical Devices & Instruments industry median Gross Margin % is 51.94. Truscreen Group's value of 31.98% is 38.4% below this industry median. Based on the distribution chart, Truscreen Group ranks #653 out of 805 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Truscreen Group's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Truscreen Group ranks #653 out of 805 companies for Gross Margin %. This places Truscreen Group in the lower half of its industry. The industry median Gross Margin % is 51.94. Truscreen Group's value of 31.98% is 38.4% below this benchmark. While the company's 10-year median is 30.63 vs. the industry median of 51.94, Truscreen Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 51.94, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Truscreen Group's current Gross Margin % of 31.98% is 38.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Truscreen Group and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 51.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Truscreen Group's current Gross Margin % is 31.98%, which is near median its own 10-year median of 30.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Truscreen Group stock overvalued right now?
Based on GuruFocus' analysis, Truscreen Group (ASX:TRU) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.01 — trading 40% above its estimated fair value. The current Gross Margin % is 31.98%, which is near median its 10-year median of 30.63 and 38.4% below the Medical Devices & Instruments industry median of 51.94. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Truscreen Group (ASX:TRU), the current Gross Margin % is 31.98% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Truscreen Group Business Description

Other Exchanges TRU:New Zealand
Address C/- HLB Mann Judd Limited, 57 Symonds Street, Level 6, Equitable House, Grafton, Auckland, NZL, 1010
Truscreen Group Ltd is a medical device company. The company manufactures and distributes the Truscreen Cervical Cancer screening device, which comprises a medical device and process designed to detect the presence in real-time of precancerous and cancerous tissue on the cervix. The product utilizes technology to detect the pre-cancerous change, or cervical intraepithelial neoplasia (CIN), by optical and electrical measurements of cervical tissue. Geographically, the company operates its business in New Zealand, Mexico, China, Russia, Zimbabwe, Vietnam, and other countries. Maximum revenue is generated from China.